Q: What is Lantus used for?

Lantus is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus .

Q: How does Lantus work?

Mechanism of Action Lantus contains insulin glargine, a man-made form of insulin. It works by replacing the insulin that the body would normally produce. Its primary function is to help move sugar (glucose) from the bloodstream into the body's cells, where it is used for energy. Additionally, it helps regulate glucose levels by signaling the liver to stop producing more sugar. Steady Release and Duration Lantus is classified as a long-acting, or basal, insulin. After it is injected under the skin, the medication forms small clusters (micro-precipitates) that dissolve slowly. This allows for a gradual and steady release of insulin into the bloodstream. Key characteristics of how it works include: Slow Onset: It typically begins to lower blood sugar several hours after injection. No Peak: Unlike short-acting insulins, Lantus is designed to have a relatively flat profile, meaning it does not have a major "peak" or surge in activity. Extended Duration: It provides a consistent level of insulin for approximately 24 hours. By maintaining a steady level of insulin in the system, Lantus helps keep blood sugar levels stable between meals and throughout the night.

Q: What are the active ingredients in Lantus?

The active ingredient in Lantus is insulin glargine .

Q: What are the side effects of Lantus?

Common side effects of Lantus may include: low blood sugar injection site reactions weight gain Always consult with a healthcare professional about potential side effects.

Q: What drug class is Lantus?

Lantus belongs to the long-acting insulin drug class.

Q: What is the dosage of Lantus and how do I take it?

How to Use Lantus Lantus is administered as an injection under the skin (subcutaneously). It is typically used once a day and should be taken at the same time every day to maintain consistent blood sugar control. Common injection sites include the abdomen, thighs, or the back of the upper arms. When administering the injection: Rotate the injection site with each dose to reduce the risk of developing skin problems, such as lumps, thickened skin, or pits. Do not inject into skin that is damaged, bruised, scaly, hard, or tender. Always check the liquid before use; it should be clear and colorless. Do not use it if it looks cloudy, colored, or contains particles. Do not mix Lantus with any other types of insulin or liquids in the same syringe, as this can change how the medication works. Missed Dose If you miss a dose of Lantus, contact your healthcare provider for guidance. Do not take an extra dose or double your dose to make up for the one you missed, as this can lead to dangerously low blood sugar.

Q: Is Lantus safe during pregnancy and breastfeeding?

Pregnancy Research involving pregnant women has not shown an increased risk of major birth defects, miscarriage, or other adverse outcomes for the mother or the baby when using Lantus. Maintaining stable blood glucose levels is essential during pregnancy to reduce the risk of complications for both the parent and the developing fetus. Insulin requirements typically fluctuate throughout pregnancy and the period immediately following delivery: First trimester: Insulin needs may decrease. Second and third trimesters: Insulin needs usually increase. Postpartum: Insulin requirements often drop rapidly after the baby is born. Breastfeeding It is not known whether insulin glargine passes into human breast milk. However, because insulin is a natural substance found in breast milk and is generally broken down in the infant's digestive tract, it is usually considered safe to use while nursing. Breastfeeding can also affect blood sugar levels, which may necessitate further adjustments to the insulin dose. Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment plan with a healthcare provider to ensure blood sugar is monitored closely and dosages are adjusted appropriately.

Q: What is the FDA approval status of Lantus?

FDA Approval and Indications Lantus was first approved by the U.S. Food and Drug Administration (FDA) in 2000. It is indicated to improve glycemic control in the following populations: Adults and pediatric patients with type 1 diabetes mellitus. Adults with type 2 diabetes mellitus. Lantus is not indicated for the treatment of diabetic ketoacidosis. Safety and Regulatory Communications Lantus does not currently carry a Boxed Warning, which is the FDA’s most serious type of warning. There is also no Risk Evaluation and Mitigation Strategy (REMS) required for this medication. In the past, the FDA evaluated post-marketing studies regarding a potential link between insulin glargine and an increased risk of cancer. After a thorough review, the FDA concluded in 2011 that the evidence was inconclusive and did not show an increased risk of cancer associated with the use of Lantus. The agency continues to monitor the safety profile of all insulin products. Biosimilar and Interchangeable Status The FDA has approved biosimilar versions of insulin glargine. Some of these products have been granted an "interchangeable" designation, which allows them to be substituted for Lantus at the pharmacy level without a new prescription from a healthcare provider, subject to state-specific laws.

Question 1

What is Lantus?

Accepted Answer

Lantus is a long-acting insulin analogue, which is a laboratory-created version of the hormone naturally produced by the pancreas. It is designed to provide a consistent level of insulin in the bloodstream over an extended period, helping to regulate the body's metabolism of carbohydrates, fats, and proteins.

This medication works by facilitating the movement of glucose from the blood into various body tissues for energy use while also limiting the amount of sugar released by the liver.

Question 2

What is Lantus used for?

Accepted Answer

Lantus is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus.

Question 3

How does Lantus work?

Accepted Answer

Mechanism of Action

Lantus contains insulin glargine, a man-made form of insulin. It works by replacing the insulin that the body would normally produce. Its primary function is to help move sugar (glucose) from the bloodstream into the body's cells, where it is used for energy. Additionally, it helps regulate glucose levels by signaling the liver to stop producing more sugar.

Steady Release and Duration

Lantus is classified as a long-acting, or basal, insulin. After it is injected under the skin, the medication forms small clusters (micro-precipitates) that dissolve slowly. This allows for a gradual and steady release of insulin into the bloodstream. Key characteristics of how it works include:

Slow Onset: It typically begins to lower blood sugar several hours after injection.
No Peak: Unlike short-acting insulins, Lantus is designed to have a relatively flat profile, meaning it does not have a major "peak" or surge in activity.
Extended Duration: It provides a consistent level of insulin for approximately 24 hours.

By maintaining a steady level of insulin in the system, Lantus helps keep blood sugar levels stable between meals and throughout the night.

Question 4

What are the active ingredients in Lantus?

Accepted Answer

The active ingredient in Lantus is insulin glargine.

Question 5

What are the side effects of Lantus?

Accepted Answer

Common side effects of Lantus may include:

low blood sugar
injection site reactions
weight gain

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Lantus?

Accepted Answer

Lantus belongs to the long-acting insulin drug class.

Question 7

What is the dosage of Lantus and how do I take it?

Accepted Answer

How to Use Lantus

Lantus is administered as an injection under the skin (subcutaneously). It is typically used once a day and should be taken at the same time every day to maintain consistent blood sugar control. Common injection sites include the abdomen, thighs, or the back of the upper arms.

When administering the injection:

Rotate the injection site with each dose to reduce the risk of developing skin problems, such as lumps, thickened skin, or pits.
Do not inject into skin that is damaged, bruised, scaly, hard, or tender.
Always check the liquid before use; it should be clear and colorless. Do not use it if it looks cloudy, colored, or contains particles.
Do not mix Lantus with any other types of insulin or liquids in the same syringe, as this can change how the medication works.

Missed Dose

If you miss a dose of Lantus, contact your healthcare provider for guidance. Do not take an extra dose or double your dose to make up for the one you missed, as this can lead to dangerously low blood sugar.

Question 8

Is Lantus safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Research involving pregnant women has not shown an increased risk of major birth defects, miscarriage, or other adverse outcomes for the mother or the baby when using Lantus. Maintaining stable blood glucose levels is essential during pregnancy to reduce the risk of complications for both the parent and the developing fetus.

Insulin requirements typically fluctuate throughout pregnancy and the period immediately following delivery:

First trimester: Insulin needs may decrease.
Second and third trimesters: Insulin needs usually increase.
Postpartum: Insulin requirements often drop rapidly after the baby is born.

Breastfeeding

It is not known whether insulin glargine passes into human breast milk. However, because insulin is a natural substance found in breast milk and is generally broken down in the infant's digestive tract, it is usually considered safe to use while nursing. Breastfeeding can also affect blood sugar levels, which may necessitate further adjustments to the insulin dose.

Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment plan with a healthcare provider to ensure blood sugar is monitored closely and dosages are adjusted appropriately.

Question 9

What forms and strengths does Lantus come in?

Accepted Answer

Lantus is a clear, colorless liquid solution intended for subcutaneous injection. It is available in two main delivery formats:

Multi-dose Vial: A glass vial containing the insulin solution, typically used with a separate insulin syringe for administration.
SoloStar Prefilled Pen: A disposable, single-patient-use injection device that contains the medication and allows for dose selection.

Question 10

What is the FDA approval status of Lantus?

Accepted Answer

FDA Approval and Indications

Lantus was first approved by the U.S. Food and Drug Administration (FDA) in 2000. It is indicated to improve glycemic control in the following populations:

Adults and pediatric patients with type 1 diabetes mellitus.
Adults with type 2 diabetes mellitus.

Lantus is not indicated for the treatment of diabetic ketoacidosis.

Safety and Regulatory Communications

Lantus does not currently carry a Boxed Warning, which is the FDA’s most serious type of warning. There is also no Risk Evaluation and Mitigation Strategy (REMS) required for this medication.

In the past, the FDA evaluated post-marketing studies regarding a potential link between insulin glargine and an increased risk of cancer. After a thorough review, the FDA concluded in 2011 that the evidence was inconclusive and did not show an increased risk of cancer associated with the use of Lantus. The agency continues to monitor the safety profile of all insulin products.

Biosimilar and Interchangeable Status

The FDA has approved biosimilar versions of insulin glargine. Some of these products have been granted an "interchangeable" designation, which allows them to be substituted for Lantus at the pharmacy level without a new prescription from a healthcare provider, subject to state-specific laws.

Question 11

What should I know about Lantus and insulin?

Accepted Answer

How Lantus Works

Lantus contains insulin glargine, a long-acting man-made version of the insulin naturally produced by the body. It is designed to lower blood glucose levels by facilitating the movement of sugar from the blood into cells, where it can be used for energy. It also prevents the liver from producing more sugar.

Basal Insulin Characteristics

Unlike rapid-acting insulins, Lantus is considered a basal insulin because it provides a consistent level of insulin throughout the day and night. Key characteristics include:

Duration: It typically works for approximately 24 hours.
No Peak: It does not have a pronounced peak of activity, which helps maintain stable blood sugar levels between meals and during sleep.
Administration: It is injected subcutaneously (under the skin) once daily at the same time each day.

Usage in Diabetes Management

Lantus is used for both type 1 and type 2 diabetes. In people with type 1 diabetes, it must be used in combination with a short-acting insulin. In people with type 2 diabetes, it may be used alone or with oral glucose-lowering medications or other types of insulin.

It is important to note that Lantus should not be used to treat diabetic ketoacidosis, as a faster-acting insulin is required for that condition.

Lantus

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Lantus

Hospitals.net Disclosure